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INTRODUCTION
The Lambert-Eaton myasthenic syndrome (LEMS) is an
uncommon presynaptic neuromuscular junction disorder. It
is associated with cancer in 50% to 60% of cases, of which
the overwhelming majority are small cell lung carcinomas
(SCLC). LEMS associated with atypical pulmonary carcinoid
tumor is extremely rare (1-3). Recently, Burns et al. reported
two cases of LEMS with atypical pulmonary carcinoids which
remitted after treatment (1). Atypical carcinoid tumors make
up about 11% of bronchopulmonary carcinoids which rep-
resent 1 to 5% of all lung tumors (6). The 5-yr survival rate
is about 60%, which is intermediate between that of typical
carcinoids (95%) and small cell carcinomas (2%) (6). We
describe here a rare case of LEMS with atypical pulmonary
carcinoid tumor, which have shown transient clinical and
electrophysiological remission after surgical resection and
chemotherapy.
CASE REPORT
A 65-yr-old man presented with progressive weakness of
legs in February 2001. He has noticed worsening difficulty
in climbing stairs before five months, which seemed to be
worse in the early mornings and then improved later in the
daytime. He has been smoking two packs of cigarettes a day
for 40 yr. The family history was unremarkable. Neurologi-
cal examination showed mild proximal arm and leg weakness
(MRC grade 4+) and hypoactive tendon reflexes. Cranial nerve
and sensory examinations were normal. Nerve conduction
study revealed low amplitude compound muscle action poten-
tials (CMAPs) in peroneal and posterior tibial nerves with
normal conduction velocities. In suspicion of LEMS, repeti-
tive nerve stimulation test (RNST) was performed on abduc-
tor digiti minimi (ADM) and tibialis anterior (TA) muscles
using Oh’s methods (4). Despite some potentiation of CMAP
after 30 sec of maximum voluntary contraction and incremen-
tal response at high rate (50 Hz) of stimulation (HRS) for 1
sec in both muscles, the results did not fully satisfied com-
monly used diagnostic criteria for LEMS (Table 1). On axon-
ally stimulated single fiber electromyography (S-SFEMG),
the jitter on the extensor digitorum communis muscle (EDC)
was markedly increased (mean of mean consecutive difference:
158  sec, upper normal limit; 25  sec) with frequent impulse
blockings (67%). Tensilon (Edrophonium) test and anti-ace-
tylcholine receptor antibody assay were negative. The amount
of salivary secretion measured by chewing gauze for 5 min
was within normal limit (7.88 mg for 5 min, low normal
limit; 7.5 mg for 5 min)(4). The second RNST 3 weeks later
showed classical LEMS pattern; 133% increment in CMAP
after short exercise, and 109% of incremental response at 50
Hz stimulation for 2 sec in ADM (Fig. 1). Chest radiography
on admission revealed a nodule in right upper lung and chest
Jae-Hyeok Lee, Jin-Hong Shin,
Dae-Seong Kim, Dae Soo Jung,
Kyu-Hyun Park, Min-Ki Lee*,
Jee-Yeon Kim
�
Department of Neurology, Pulmonology*, and 
Pathology




Department of Neurology, Pusan National University
Hospital, 10 1-ga, Ami-dong, Seo-gu, Busan 602-739,
Korea
Tel : +82.51-240-7672, Fax : +82.51-245-2783
E-mail : dskim@pusan.ac.kr
753
J Korean Med Sci 2004; 19: 753-5
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
A Case of Lambert-Eaton Myasthenic Syndrome Associated with
Atypical Bronchopulmonary Carcinoid Tumor
The Lambert-Eaton myasthenic syndrome (LEMS) is typically recognized as a para-
neoplastic syndrome associated with a small cell lung carcinoma (SCLC), whereas
LEMS with other neuroendocrine lung tumors, including carcinoids or large cell lung
carcinoma, are highly unusual. Here, we report a rare case of LEMS with atypical
bronchopulmonary carcinoid tumor: A 65-yr-old man presented with progressive leg
weakness and a diagnosis of LEMS was made by serial repetitive nerve stimulation
test. Chest CT revealed a lung nodule with enlargement of paratracheal lymph nodes,
and surgically resected lesion showed pathological features of atypical carcinoid
tumor. We concluded that LEMS could be associated with rare pulmonary neuroen-
docrine tumor other than SCLC, which necessitates pathologic confirmation followed
by aggressive treatment for optimal management in these rare cases.
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CT disclosed a speculated, 1.4 cm-sized enhancing nodule
and enlarged right upper paratracheal lymph node (Fig. 2A).
The material from CT-guided needle biopsy showed malig-
nant tumor cells, which was initially read out as adenocarci-
noma. After two serial courses of chemotherapy with pacli-
taxol and carboplatin, the nodule in right upper lobe and
mediastinal lymph node were resected in May 2001. Detailed
microscopic examination showed mosaic pattern with cellu-
CMAP
Date
Muscle Rest (mV) PEF (%) 2 Hz 3 Hz 5 Hz 1 sec 2 sec Jitter % blocking
LRS (%) HRS (%) S-SFEMG*
2001. 2. 23 ADM 8.2 +70 -21 -22 -17 +30 158
� 67
EDB 1.6 +88 -33 -33 -25 +74
3.16 ADM 5.8 +133 -31 -34 -31 +78 +109 144
� 100
7.20 ADM 10.3 +23 -2 -6 -4 +10 33
� 0
2002. 5.18 ADM 10.3 +54 -25 -31 -26 +22 +43
8.29 ADM 6.7 +75 -31 -35 -33 +145
Table 1. Serial data of repetitive nerve stimulation test and stimulated single fiber electromyography
CMAP, compound muscle action potential; LRS, low rate of stimulation; HRS, high rate stimulation; S-SFEMG, stimulated single fiber EMG; PEF, pos-
texercise fascilitation; ADM, abductor digiti minimi; EDB, extensor digitorum brevis; +, incremental response; -, decremental response.
*S-SFEMG was performed on the extensor digitorum communis muscle (EDC) at stimulation rate of 10 Hz. 
�
Increased mean of mean consecutive dif-
ference (upper normal limits; 25  sec).
Fig. 1. Postexercise fascilitation and incremental response at high rate of stimuration in the abductor digiti minimi muscle. Note definite
facilitation at high rate of stimulation is achieved by prolonged stimulation for 2 sec in second test. (A) Compound muscle action potential
(CMAP) before exercise. (B) CMAP after 30 sec of exercise. (C) Response at 50/sec stimulation for 1 sec. (D) Response at 50/sec stimu-
lation for 2 sec.



















Fig. 2. (A) CT scan of the chest shows a 1.4 cm nodule (arrow) in the posterior segment of right upper lobe. (B) Atypical carcinoid tumor
with mosaic patterns separated by thin fibrovascular stroma. The tumor cells have central round nuclei with abundant cytoplasm (H&E ×100).
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lar pleomorphism and increased mitotic activity, which is
considered intermediate between that of typical carcinoid and
small cell carcinoma. Immunohistochemical stains for neu-
roendocrine markers, such as chromogranin A, synaptophysin,
and neuron-specific enolase were all positive and was finally
interpreted as atypical carcinoid (Fig. 2B). The antibody titer
against the P/Q type voltage-gated calcium channel, sent after
surgical resection was negative (less than 1.0 pmol/L; upper
limit of normal; 20 pmol/L). After surgery, his strength has
improved to almost premorbid level. The typical RNS fea-
tures of LEMS normalized 2 months later (Table 1) and S-
SFEMG findings also improved. However, his improvement
was shortlived. In May 2002, he was reevaluated due to clin-
ical worsening, showing a waddling of gait and fatigable
weakness of proximal muscles in all limbs. Tumor recurrence
was detected on chest CT. RNST abnormalities recurred as
the same patterns as the initial test; normal CMAP, decremen-
tal response at LRS, and mild incremental response at HRS.
It was 3 months after tumor recurrence that 145% of incre-
mental response at HRS was achieved (Table 1). Despite sev-
eral additional cycles of chemotherapy, he remained mildly
disabled.
DISCUSSION
We describe a rare case of LEMS associated with atypical
bronchopulmonary carcinoid tumor. No more than 5 cases
could be found in English literatures (1-3), all of which, how-
ever, lacked description of detailed clinical features and elec-
trophysiological patterns.
LEMS results from an autoimmune attack directed against
the voltage-gated calcium channels (VGCCs) on the presy-
naptic motor nerve terminal. It was first described as a para-
neoplastic syndrome in patients with lung cancer but we now
know about half of the patients with LEMS do not have can-
cer. When tumor occurs in LEMS, it is usually SCLC (5, 9).
Recently, Burns et al. (1) reported LEMS associated with
other pulmonary neuroendocrine carcinomas with prolonged
remission; two patients with atypical carcinoids and one pa-
tient with large cell neuroendocine carcinoma. In the spec-
trum of neuroendocrine tumors of the lung, which can be
divided into the typical carcinoid, atypical carcinoid, SCLC
and large cell neuroendocrine carcinoma, atypical carcinoids
occupy the middle ground in terms of pathological features
as well as natural history and prognosis (6). LEMS in the
setting of underlying atypical carcinoid lung tumor, unlike
those associated with SCLC, may be better responsive to treat-
ment with variable long-term remission (1). In our case, clin-
ical and electrophysiological remission was achieved by sur-
gical resection and chemotherapy, but failed to remain in pro-
longed remission after tumor recurrence.
It is noteworthy that our case initially did not satisfy the
electrophysiological criteria of LEMS, and the follow-up study
3 weeks later revealed marked facilitation of CMAP compat-
ible with LEMS. It is known that electrophysiologic findings
of LEMS may occasionally overlap with those seen in myas-
thenia gravis; a decremental response at low stimulations rate,
normal CMAP amplitudes and absent facilitation at high
stimulation rate. Furthermore, facilitation up to 50% can also
be seen in myasthenia gravis (7), complicating electrophysi-
ologic diagnosis not to be straightforward between the two
myasthenic syndromes. Otherwise, it is believed that these
patterns represent a mild form of LEMS, based on the obser-
vation that many LEMS patients show these patterns as they
improve with treatment (8). Our case demonstrates how re-
peated serial RNST can help diagnosis when initial findings
are equivocal. In addition, prolonged stimulation up to 2 sec
or more may be needed for full extent of facilitation (8).
We concluded that LEMS could be associated with pulmo-
nary neuroendocrine tumor other than SCLC, which necessi-
tates pathologic confirmation followed by aggressive treatment
for optimal management in these rare cases.
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